Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.

Gibson MK, Zaidi AH, Davison JM, Sanz AF, Hough B, Komatsu Y, Kosovec JE, Bhatt A, Malhotra U, Foxwell T, Rotoloni CL, Hoppo T, Jobe BA.

Ann Surg. 2013 Jul;258(1):82-8. doi: 10.1097/SLA.0b013e318270500d.

PMID:
23108119
2.

Suitability of surgically induced chronic reflux in rats for studying esophageal carcinogenesis.

Gronnier C, Piessen G, Leteurtre E, Van Seuningen I, Mariette C.

Ann Surg. 2015 May;261(5):e140-1. doi: 10.1097/SLA.0000000000000474. No abstract available.

PMID:
24374550
3.

Reply to letter: "surgically induced rat reflux model ideal for study of esophageal carcinogenesis".

Jobe BA, Zaidi AH.

Ann Surg. 2015 May;261(5):e141-2. doi: 10.1097/SLA.0000000000000475. No abstract available.

PMID:
24424138
4.

Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.

Kumagai H, Mukaisho K, Sugihara H, Miwa K, Yamamoto G, Hattori T.

Carcinogenesis. 2004 May;25(5):723-7. Epub 2004 Jan 30.

PMID:
14754873
5.

Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats.

Melo LL, Kruel CD, Kliemann LM, Cavazzola LT, Boeno Rda L, Silber PC, Grossi RS.

Dis Esophagus. 1999;12(2):106-15.

PMID:
10466042
6.

Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.

Chu YX, Wang WH, Dai Y, Teng GG, Wang SJ.

World J Gastroenterol. 2014 Nov 14;20(42):15715-26. doi: 10.3748/wjg.v20.i42.15715.

7.

Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?

Pondugula K, Wani S, Sharma P.

Curr Gastroenterol Rep. 2007 Dec;9(6):468-74. Review.

PMID:
18377797
8.

Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen.

Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS.

Carcinogenesis. 1997 Nov;18(11):2265-70.

PMID:
9395230
9.

Oxidative damage in an esophageal adenocarcinoma model with rats.

Chen X, Ding YW, Yang Gy, Bondoc F, Lee MJ, Yang CS.

Carcinogenesis. 2000 Feb;21(2):257-63.

PMID:
10657966
10.

Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.

Esquivias P, Morandeira A, Escartín A, Cebrián C, Santander S, Esteva F, García-González MA, Ortego J, Lanas A, Piazuelo E.

World J Gastroenterol. 2012 Sep 21;18(35):4866-74.

11.

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.

Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ.

Gastroenterology. 2002 Apr;122(4):1101-12.

PMID:
11910360
12.

Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux.

Cheng P, Gong J, Wang T, Chen J, Liu GS, Zhang R.

World J Gastroenterol. 2005 Sep 7;11(33):5117-22.

13.

Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.

Samuels T, Hoekzema C, Gould J, Goldblatt M, Frelich M, Bosler M, Lee SH, Johnston N.

Ann Otol Rhinol Laryngol. 2015 Nov;124(11):893-902. doi: 10.1177/0003489415590657. Epub 2015 Jun 15.

14.

An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload.

Chen X, Yang Gy, Ding WY, Bondoc F, Curtis SK, Yang CS.

Carcinogenesis. 1999 Sep;20(9):1801-8.

PMID:
10469627
15.

Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.

Kauttu TM, Rantanen TK, Sihvo EI, Räsänen JV, Puolakkainen P, Salo JA.

Eur J Cardiothorac Surg. 2011 Dec;40(6):1450-4; discussion 1454. doi: 10.1016/j.ejcts.2011.02.075. Epub 2011 May 4.

PMID:
21546258
16.

Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus.

Cheng P, Li JS, Zhang LF, Chen YZ, Gong J.

World J Gastroenterol. 2013 Apr 21;19(15):2419-24. doi: 10.3748/wjg.v19.i15.2419.

17.

[A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].

Miwa K, Oyama K, Fujimura T.

Nihon Rinsho. 2005 Aug;63(8):1387-93. Japanese.

PMID:
16101227
18.

Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells.

Zaidi AH, Komatsu Y, Kelly LA, Malhotra U, Rotoloni C, Kosovec JE, Zahoor H, Makielski R, Bhatt A, Hoppo T, Jobe BA.

Cancer Invest. 2013 Aug;31(7):480-9. doi: 10.3109/07357907.2013.820317.

PMID:
23915072
19.

Effects of refluxate pH values on duodenogastroesophageal reflux-induced esophageal adenocarcinoma.

Cheng P, Li JS, Gong J, Zhang LF, Chen RZ.

World J Gastroenterol. 2011 Jul 7;17(25):3060-5. doi: 10.3748/wjg.v17.i25.3060.

20.

Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.

Chang JT, Katzka DA.

Arch Intern Med. 2004 Jul 26;164(14):1482-8. Review.

PMID:
15277277

Supplemental Content

Support Center